Patients Response to Early Switch To Oral:Osteomyelitis Study
Status:
Terminated
Trial end date:
2018-11-07
Target enrollment:
Participant gender:
Summary
Based on the current literature, investigators hypothesize that patients with osteomyelitis
who are treated with the standard approach of intravenous antibiotics for the full duration
of therapy will have the same clinical outcomes as patients treated with the experimental
approach of intravenous antibiotics with early switch to oral antibiotics.
The primary objective of this study is to compare patients with osteomyelitis treated with
the standard approach of intravenous antibiotics for the full duration of therapy versus
patients treated with intravenous antibiotics with an early switch to oral antibiotics in
relation to clinical outcomes at 12 months after discontinuation of antibiotic therapy.
Secondary objectives of the study include the evaluation of adverse events related to the use
of antibiotics as well as the cost of care evaluated from the hospital perspective.
Phase:
Early Phase 1
Details
Lead Sponsor:
Julio Ramirez
Collaborators:
James Graham Brown Cancer Center University of Louisville